Financial Statements

Therapix Biosciences Ltd.

Therapix Biosciences Ltd. (TRPX)

-0.313 (-49.68%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2018 2017 2016
Retained Earnings (Previous Year) -38-31-
Net Income -9-6-
Stock Dividends --1-31
Dividend Paid ---
Retained Earnings -47-38-31

PPE Schedule

Year 2018 2017 2016
Gross PPE 00-
Annual Depreciation 200
Capital Expenditure -0-0-
Net PPE 200

Intangible and Goodwill Schedule

Year 2018 2017 2016
Intangible and Goodwill (Previous Year) ---
New Purchases ---
Intangible and Goodwill ---

Therapix Biosciences Ltd. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Therapix Biosciences Ltd. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.